查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1494770

到 2030 年神經修復和再生市場預測：按產品類型、病理類型、應用、最終用戶和地區進行的全球分析

Nerve Repair and Regeneration Market Forecasts to 2030 - Global Analysis By Product Type (Biomaterials, Neuromodulation Devices and Other Product Types), Condition Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC預測，2024年全球神經修復與再生市場規模將達103億美元，預計2030年將達到253億美元，預測期內複合年成長率為16.1%。

神經修復和再生是指將體內受損或受傷的神經恢復到功能狀態的自然或輔助過程。這涉及受損神經組織的修復和神經纖維的再生，從而恢復感覺和運動功能。這些過程在某種程度上在體內自然發生，但也可以透過手術、神經移植和再生療法等醫療介入來促進。最終目標是恢復神經功能並加速神經損傷或殘疾的恢復。

據阿茲海默症協會稱，到2022年，65歲以上的美國人將有650萬人患有阿茲海默症。

老年人口增加

該市場的成長很大程度上得益於老年人口的增加。隨著醫療保健的進步，越來越多的老年人正在尋求神經相關疾病的治療。這種人口結構的變化正在推動對神經修復和再生創新解決方案的需求。由於老年人面臨神經病變和損傷等挑戰，迫切需要恢復功能和改善生活品質的治療方法。這一趨勢凸顯了市場擴張和創新的潛力。

目前的治療方法效果有限

由於目前治療方法的有效性有限，市場面臨重大挑戰。儘管取得了進展，但許多現有方法仍難以完全恢復神經功能，尤其是在複雜的情況下。這項限制凸顯了對創新解決方案的迫切需求，這些解決方案可以改善再生結果並滿足不同的患者需求。開拓高度成功且廣泛適用的治療方法仍然是克服市場面臨的障礙的重要目標。

技術進步

神經修復和再生技術的最新趨勢包括開發生物工程神經移植物，例如神經導管和支架，以促進神經再生。此外，幹細胞療法、基因療法和神經組織工程等創新方法已顯示出增強神經修復效果的潛力。先進的影像技術和神經刺激技術也有助於繪製神經途徑並促進神經再生。

昂貴的程序費用

這個市場的治療成本很高，對尋求治療的患者造成了巨大的經濟障礙。它們通常花費數千甚至數萬美元，並且易用性是一個主要問題。這些高昂的費用延伸到外科手術、專業診斷和術後護理，加重了個人和醫療保健系統的經濟負擔。應對這項挑戰對於確保公平獲得基本的神經修復和再生治療至關重要。

COVID-19 的影響：

COVID-19 大流行嚴重影響了神經修復和再生市場，導致醫療服務中斷和擇期手術延遲。患者就診和外科手術的減少導致市場成長下降。供應鏈中斷也阻礙了醫療設備和治療的取得。然而，隨著醫療保健服務逐漸恢復以及對神經損傷的認知增強，市場有望復甦。遠端醫療和遠端患者監護的創新可能會重塑市場動態，並推動神經修復和再生技術的未來成長。

預計生醫材料領域在預測期內將是最大的。

預計生物材料在預測期內將佔據最大佔有率。這些生醫材料，包括水凝膠、支架和導管，為修復受損神經和促進再生提供了有前景的解決方案。神經損傷發生率的增加和微創手術技術的日益採用進一步推動了市場擴張。此外，正在進行的研究工作和合作旨在提高這些生物材料的有效性和可及性，並推動市場持續成長。

醫院和診所領域預計在預測期內複合年成長率最高

預計醫院和診所產業在預測期內將經歷最高的複合年成長率。這些設施配備了先進的技術，並配備了專注於恢復神經功能和改善患者生活品質的專業醫療專業人員。從神經移植到神經刺激療法，這些中心根據個人需求提供全面的服務，推動神經病學的進步，並為神經損傷和病症患者帶來希望。

比最大的地區

由於神經損傷和疾病的盛行率不斷增加、技術進步以及對創新治療方案的需求不斷成長，預計北美將在預測期內佔據最大的市場佔有率。成熟的醫療基礎設施、支持性報銷政策和人口老化加劇等因素正在促進市場擴張。主要參與者正專注於開發新治療方法和擴大產品系列，進一步推動市場成長。

複合年成長率最高的地區：

由於多種因素，亞太地區將在預測期內經歷最高的複合年成長率，包括神經損傷發生率的增加、老年人口的增加、神經修復治療意識的提高以及醫療基礎設施和技術的進步預計將得到維持。此外，政府和私人機構對研發活動的投資增加也刺激了該地區神經修復和再生技術的創新。

提供免費客製化：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球神經修復與再生市場：依產品類型

  • 生物材料
    • 神經導管
    • 神經保護劑
    • 神經繃帶
    • 神經連接器
  • 神經調節裝置
    • 內神經刺激設備
      • 脊髓刺激設備
      • 深層腦部刺激器
      • 薦骨神經刺激器
      • 迷走神經刺激設備
    • 外部神經刺激設備
      • 經皮神經電刺激 (TENS)
      • 經顱磁刺激（TMS）
      • 呼吸電刺激設備
  • 其他產品類型

第6章全球神經修復與再生市場：依疾病類型

  • 外傷性神經損傷
  • 神經退化性疾病
  • 神經壓迫症候群
  • 週邊神經病變
  • 其他疾病類型

第7章全球神經修復與再生市場：依應用分類

  • 神經移植
    • 自體移植
    • 同種異體移植
    • 異種移植
  • 幹細胞療法
    • 間質幹細胞（MSC）
    • 造血幹細胞（HSC）
    • 神經幹細胞（NSC）
  • 直接神經修復
    • 神經外膜修復
    • 神經周圍修復
    • 組束脩復
  • 其他用途

第8章全球神經修復與再生市場：依最終用戶分類

  • 醫院和診所
  • 日間手術中心 (ASC)
  • 研究實驗室和學術機構
  • 其他最終用戶

第9章全球神經修復與再生市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Medtronic, Plc.
  • Synovis Micro Companies Alliance
  • Axogen Corporation
  • Checkpoint Surgical
  • Synapse Biomedical Inc.
  • Polyganics
  • Boston scientific inc
  • Nuvectra Corporation
  • Abbott Laboratories
  • OrthoMed, Inc
  • NeuroSigma, Inc.
  • Stryker Corporation
  • Allergan plc
  • Baxter International Inc.
  • Collagen Matrix, Inc.
  • Integra LifeSciences Holdings Corporation
Product Code: SMRC26285

According to Stratistics MRC, the Global Nerve Repair and Regeneration Market is accounted for $10.3 billion in 2024 and is expected to reach $25.3 billion by 2030 growing at a CAGR of 16.1% during the forecast period. Nerve repair and regeneration refer to the natural or assisted processes by which damaged or injured nerves in the body are restored to their functional state. This involves the repair of damaged nerve tissue and the regeneration of nerve fibers, allowing for the restoration of sensory and motor functions. These processes can occur spontaneously to some extent in the body, but they can also be facilitated through medical interventions such as surgery, nerve grafting, or the use of regenerative therapies. The ultimate goal is to restore nerve function and facilitate recovery from nerve injuries or disorders.

According to the Alzheimer's Association, in 2022, 6.5 million people aged 65 or more in America were suffering from Alzheimer's disease.

Market Dynamics:

Driver:

Growing geriatric population

The market is experiencing significant growth, largely due to the increasing geriatric population. With advancements in healthcare, more elderly individuals are seeking treatments for nerve-related conditions. This demographic shift has fueled demand for innovative solutions catering to nerve repair and regeneration. As older adults face challenges such as neuropathy and nerve injuries, there's a pressing need for therapies that can restore function and improve quality of life. This trend underscores the market's potential for expansion and innovation.

Restraint:

Limited efficacy of current treatments

The market faces significant challenges due to the limited efficacy of current treatments. Despite advancements, many existing approaches struggle to fully restore nerve function, especially in complex cases. This limitation underscores the pressing need for innovative solutions that can enhance regeneration outcomes and address diverse patient needs. Developing therapies with higher success rates and broader applicability remains a critical goal in overcoming the hurdles faced by the market.

Opportunity:

Technological advancements

Recent advancements in nerve repair and regeneration technology include the development of bioengineered nerve grafts, such as nerve conduits and scaffolds, to promote nerve regeneration. Additionally, innovative approaches like stem cell therapy, gene therapy, and nerve tissue engineering have shown promise in enhancing nerve repair outcomes. Advanced imaging techniques and neurostimulation methods also aid in mapping nerve pathways and facilitating nerve regeneration.

Threat:

High cost of procedures

The market is marked by steep procedure costs, posing significant financial barriers for patients seeking treatment. With expenses often ranging in the thousands, if not tens of thousands, of dollars, accessibility becomes a major concern. These high costs encompass surgical procedures, specialized diagnostics, and post-operative care, amplifying the financial strain on individuals and healthcare systems alike. Addressing this challenge is crucial for ensuring equitable access to essential nerve repair and regeneration therapies.

Covid-19 Impact:

The COVID-19 pandemic significantly affected the Nerve Repair and Regeneration market, causing disruptions in healthcare services and delaying elective procedures. Reduced patient visits and surgical interventions led to a decline in market growth. Supply chain disruptions also hampered the availability of medical devices and treatments. However, with the gradual recovery of healthcare services and increased awareness of nerve injuries, the market is expected to rebound. Innovations in telemedicine and remote patient monitoring might reshape the market dynamics, driving future growth in nerve repair and regeneration technologies.

The biomaterials segment is expected to be the largest during the forecast period

The biomaterials is expected to be the largest during the forecast period. These biomaterials include hydrogels, scaffolds, and conduits, offer promising solutions for repairing damaged nerves and promoting regeneration. The market's expansion is further propelled by rising incidences of nerve injuries, coupled with the increasing adoption of minimally invasive surgical techniques. Additionally, ongoing research efforts and collaborations aim to enhance the efficacy and accessibility of these biomaterials, fostering continued market growth.

The hospitals and clinics segment is expected to have the highest CAGR during the forecast period

The hospitals and clinics segment is expected to have the highest CAGR during the forecast period. These facilities are equipped with advanced technologies and staffed by expert medical professionals who focus on restoring nerve function and improving patients' quality of life. From nerve grafting to nerve stimulation therapies, these centers offer comprehensive services tailored to individual needs, driving advancements in neurological medicine and fostering hope for those with nerve injuries or conditions.

Region with largest share:

North America is projected to hold the largest market share during the forecast period driven by increasing prevalence of nerve injuries and disorders, technological advancements, and rising demand for innovative treatment options. Factors such as a well-established healthcare infrastructure, supportive reimbursement policies, and a growing aging population contribute to market expansion. Key players are focusing on developing novel therapies and expanding their product portfolios, further fueling market growth.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period due to several factors such as increasing incidences of nerve injuries, growing geriatric population, rising awareness about nerve repair treatments, and advancements in healthcare infrastructure and technologies. Additionally, the increasing investments in research and development activities by both government and private organizations are fueling innovation in nerve repair and regeneration technologies in the region.

Key players in the market

Some of the key players in Nerve Repair and Regeneration market include Medtronic, Plc., Synovis Micro Companies Alliance, Axogen Corporation, Checkpoint Surgical, Synapse Biomedical Inc., Polyganics, Boston scientific inc, Nuvectra Corporation, Abbott Laboratories, OrthoMed, Inc NeuroSigma, Inc., Stryker Corporation, Allergan plc, Baxter International Inc., Collagen Matrix, Inc. and Integra LifeSciences Holdings Corporation

Key Developments:

In March 2024, Medtronic announced the launch of the new UNiD(TM) ePRO service in the United States. This solution will change the way patient outcomes are collected for spine surgeons, reducing the burden on clinic staff and patients. Medtronic has partnered with OBERD, a leading practice intelligence data collection company, to provide spine surgeons with an electronic Patient Reported Outcomes (ePRO) system.

In November 2023, Medtronic launched a new frontier in treating high blood pressure. The U.S. Food and Drug Administration (FDA) today approved the Medtronic Symplicity Spyral(TM) renal denervation system for use in the United States. The system, which carries the FDA's Breakthrough Device designation, uses radio frequency to disrupt overactive nerves in the kidneys and help lower blood pressure.

Product Types Covered:

  • Biomaterials
  • Neuromodulation Devices
  • Other Product Types

Condition Types Covered:

  • Traumatic Nerve Injuries
  • Neurodegenerative Diseases
  • Nerve Compression Syndromes
  • Peripheral Neuropathies
  • Other Condition Types

Applications Covered:

  • Nerve Grafting
  • Stem Cell Therapy
  • Direct Nerve Repair
  • Other Applications

End Users Covered:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Research Laboratories and Academic Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Nerve Repair and Regeneration Market, By Product Type

  • 5.1 Introduction
  • 5.2 Biomaterials
    • 5.2.1 Nerve Conduits
    • 5.2.2 Nerve Protectors
    • 5.2.3 Nerve Wraps
    • 5.2.4 Nerve Connectors
  • 5.3 Neuromodulation Devices
    • 5.3.1 Internal Neurostimulation Devices
      • 5.3.1.1 Spinal Cord Stimulators
      • 5.3.1.2 Deep Brain Stimulators
      • 5.3.1.3 Sacral Nerve Stimulators
      • 5.3.1.4 Vagus Nerve Stimulators
    • 5.3.2 External Neurostimulation Devices
      • 5.3.2.1 Transcutaneous Electrical Nerve Stimulation (TENS)
      • 5.3.2.2 Transcranial Magnetic Stimulation (TMS)
      • 5.3.2.3 Respiratory Electrical Stimulation Devices
  • 5.4 Other Product Types

6 Global Nerve Repair and Regeneration Market, By Condition Type

  • 6.1 Introduction
  • 6.2 Traumatic Nerve Injuries
  • 6.3 Neurodegenerative Diseases
  • 6.4 Nerve Compression Syndromes
  • 6.5 Peripheral Neuropathies
  • 6.6 Other Condition Types

7 Global Nerve Repair and Regeneration Market, By Application

  • 7.1 Introduction
  • 7.2 Nerve Grafting
    • 7.2.1 Autografts
    • 7.2.2 Allografts
    • 7.2.3 Xenografts
  • 7.3 Stem Cell Therapy
    • 7.3.1 Mesenchymal Stem Cells (MSCs)
    • 7.3.2 Hematopoietic Stem Cells (HSCs)
    • 7.3.3 Neural Stem Cells (NSCs)
  • 7.4 Direct Nerve Repair
    • 7.4.1 Epineural Repair
    • 7.4.2 Perineural Repair
    • 7.4.3 Group Fascicular Repair
  • 7.5 Other Applications

8 Global Nerve Repair and Regeneration Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals and Clinics
  • 8.3 Ambulatory Surgical Centers (ASCs)
  • 8.4 Research Laboratories and Academic Institutes
  • 8.5 Other End Users

9 Global Nerve Repair and Regeneration Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Medtronic, Plc.
  • 11.2 Synovis Micro Companies Alliance
  • 11.3 Axogen Corporation
  • 11.4 Checkpoint Surgical
  • 11.5 Synapse Biomedical Inc.
  • 11.6 Polyganics
  • 11.7 Boston scientific inc
  • 11.8 Nuvectra Corporation
  • 11.9 Abbott Laboratories
  • 11.10 OrthoMed, Inc
  • 11.11 NeuroSigma, Inc.
  • 11.12 Stryker Corporation
  • 11.13 Allergan plc
  • 11.14 Baxter International Inc.
  • 11.15 Collagen Matrix, Inc.
  • 11.16 Integra LifeSciences Holdings Corporation

List of Tables

  • Table 1 Global Nerve Repair and Regeneration Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Nerve Repair and Regeneration Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Nerve Repair and Regeneration Market Outlook, By Biomaterials (2022-2030) ($MN)
  • Table 4 Global Nerve Repair and Regeneration Market Outlook, By Nerve Conduits (2022-2030) ($MN)
  • Table 5 Global Nerve Repair and Regeneration Market Outlook, By Nerve Protectors (2022-2030) ($MN)
  • Table 6 Global Nerve Repair and Regeneration Market Outlook, By Nerve Wraps (2022-2030) ($MN)
  • Table 7 Global Nerve Repair and Regeneration Market Outlook, By Nerve Connectors (2022-2030) ($MN)
  • Table 8 Global Nerve Repair and Regeneration Market Outlook, By Neuromodulation Devices (2022-2030) ($MN)
  • Table 9 Global Nerve Repair and Regeneration Market Outlook, By Internal Neurostimulation Devices (2022-2030) ($MN)
  • Table 10 Global Nerve Repair and Regeneration Market Outlook, By Spinal Cord Stimulators (2022-2030) ($MN)
  • Table 11 Global Nerve Repair and Regeneration Market Outlook, By Deep Brain Stimulators (2022-2030) ($MN)
  • Table 12 Global Nerve Repair and Regeneration Market Outlook, By Sacral Nerve Stimulators (2022-2030) ($MN)
  • Table 13 Global Nerve Repair and Regeneration Market Outlook, By Vagus Nerve Stimulators (2022-2030) ($MN)
  • Table 14 Global Nerve Repair and Regeneration Market Outlook, By External Neurostimulation Devices (2022-2030) ($MN)
  • Table 15 Global Nerve Repair and Regeneration Market Outlook, By Transcutaneous Electrical Nerve Stimulation (TENS) (2022-2030) ($MN)
  • Table 16 Global Nerve Repair and Regeneration Market Outlook, By Transcranial Magnetic Stimulation (TMS) (2022-2030) ($MN)
  • Table 17 Global Nerve Repair and Regeneration Market Outlook, By Respiratory Electrical Stimulation Devices (2022-2030) ($MN)
  • Table 18 Global Nerve Repair and Regeneration Market Outlook, By Other Product Types (2022-2030) ($MN)
  • Table 19 Global Nerve Repair and Regeneration Market Outlook, By Condition Type (2022-2030) ($MN)
  • Table 20 Global Nerve Repair and Regeneration Market Outlook, By Traumatic Nerve Injuries (2022-2030) ($MN)
  • Table 21 Global Nerve Repair and Regeneration Market Outlook, By Neurodegenerative Diseases (2022-2030) ($MN)
  • Table 22 Global Nerve Repair and Regeneration Market Outlook, By Nerve Compression Syndromes (2022-2030) ($MN)
  • Table 23 Global Nerve Repair and Regeneration Market Outlook, By Peripheral Neuropathies (2022-2030) ($MN)
  • Table 24 Global Nerve Repair and Regeneration Market Outlook, By Other Condition Types (2022-2030) ($MN)
  • Table 25 Global Nerve Repair and Regeneration Market Outlook, By Application (2022-2030) ($MN)
  • Table 26 Global Nerve Repair and Regeneration Market Outlook, By Nerve Grafting (2022-2030) ($MN)
  • Table 27 Global Nerve Repair and Regeneration Market Outlook, By Autografts (2022-2030) ($MN)
  • Table 28 Global Nerve Repair and Regeneration Market Outlook, By Allografts (2022-2030) ($MN)
  • Table 29 Global Nerve Repair and Regeneration Market Outlook, By Xenografts (2022-2030) ($MN)
  • Table 30 Global Nerve Repair and Regeneration Market Outlook, By Stem Cell Therapy (2022-2030) ($MN)
  • Table 31 Global Nerve Repair and Regeneration Market Outlook, By Mesenchymal Stem Cells (MSCs) (2022-2030) ($MN)
  • Table 32 Global Nerve Repair and Regeneration Market Outlook, By Hematopoietic Stem Cells (HSCs) (2022-2030) ($MN)
  • Table 33 Global Nerve Repair and Regeneration Market Outlook, By Neural Stem Cells (NSCs) (2022-2030) ($MN)
  • Table 34 Global Nerve Repair and Regeneration Market Outlook, By Direct Nerve Repair (2022-2030) ($MN)
  • Table 35 Global Nerve Repair and Regeneration Market Outlook, By Epineural Repair (2022-2030) ($MN)
  • Table 36 Global Nerve Repair and Regeneration Market Outlook, By Perineural Repair (2022-2030) ($MN)
  • Table 37 Global Nerve Repair and Regeneration Market Outlook, By Group Fascicular Repair (2022-2030) ($MN)
  • Table 38 Global Nerve Repair and Regeneration Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 39 Global Nerve Repair and Regeneration Market Outlook, By End User (2022-2030) ($MN)
  • Table 40 Global Nerve Repair and Regeneration Market Outlook, By Hospitals and Clinics (2022-2030) ($MN)
  • Table 41 Global Nerve Repair and Regeneration Market Outlook, By Ambulatory Surgical Centers (ASCs) (2022-2030) ($MN)
  • Table 42 Global Nerve Repair and Regeneration Market Outlook, By Research Laboratories and Academic Institutes (2022-2030) ($MN)
  • Table 43 Global Nerve Repair and Regeneration Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.